TABLE 2.
Fluoroquinolone susceptibilities of S. pneumoniae C3LN4, first-step mutants, and clinical isolates
| Strain | Fluoroquinolone MIC (μg/ml)a
|
||||
|---|---|---|---|---|---|
| LVFX | OFLX | CPFX | SPFX | STFX | |
| C3LN4 | 0.1 | 0.3 | 0.2 | 0.15 | 0.005 |
| SPFX1b | 0.1 | 0.3 | 0.2 | 0.4 | 0.005 |
| CPFX1c | 0.1 | 0.3 | 0.5 | 0.15 | 0.005 |
| OFLX1d | 0.3 | 0.75 | 0.6 | 0.8 | 0.005 |
| JP17e | 6.25 | 12.5 | 6.25 | 1.56 | 0.39 |
| JP27e | 25 | 50 | 50 | 25 | 0.39 |
LVFX, levofloxacin; OFLX, ofloxacin; CPFX, ciprofloxacin; SPFX, sparfloxacin; STFX, sitafloxacin. Those MICs greater than those for the wild type are shown in boldface type.
Selected with sparfloxacin (the MICs for the other five mutants were identical).
Selected with ciprofloxacin (MICs for the other 11 mutants were identical).
Selected with ofloxacin.
Clinical isolates.